North China Pharmaceutical Group Co., Ltd. is the largest pharmaceutical enterprise in China, located in Shijiazhuang, the capital of Hebei Province. The company's predecessor, North China Pharmaceutical Factory, was a national key construction project during the First Five-Year Plan period. It consists of an antibiotic factory, a starch factory and a medical glass factory imported from the former Democratic Republic of Germany in the 156 key project aided by the former Soviet Union. Construction started on June 1953, with a total investment of 75.88 million yuan, and was put into operation on June 1958. The establishment of North China Pharmaceutical Factory initiated the history of large-scale production of antibiotics in China, ended the history of China's dependence on imported penicillin and streptomycin, and the situation of lack of doctors and medicines was obviously improved.
Since its establishment 40 years ago, Huayao has been operating steadily, expanding gradually, expanding its business scope, increasing its sales volume and maintaining excellent performance. Its main economic indicators have been in the forefront of the same industry in China. Compared with when it was put into production, its business scope expanded from simple pharmacy to biology, chemicals, pesticides, commerce and other fields, and its main products increased from 5 to more than 430 varieties, and from a factory with a single property right structure to more than 30 subsidiaries, with diversified products. By the end of 200 1, the total assets of Huayao Pharmaceutical Industry15.5 billion yuan, the production area130,000 square meters, and the employees18,500 people. The accumulated profits and taxes reached 965.438 billion yuan, the national profits and taxes reached 6.95 billion yuan, and the accumulated export earned 630 million US dollars. In the first half of 2002, Huayao completed a total industrial output value of 4.43 billion yuan, realized sales income of 365.438+0.8 billion yuan, realized profits of 65.438+0.9 billion yuan and realized profits and taxes of 320 million yuan.
Industry status
Huayao Group Co., Ltd. is the largest chemical pharmaceutical enterprise in China, and has been ranked among the top 500 industrial enterprises in China and the industrial enterprises with the best economic benefits for many years. 1986, won the "National Quality Management Award" for the first time in the pharmaceutical industry. 199 1 established a new drug research and development center, which is the first enterprise technology center recognized by the state in the pharmaceutical industry. 199 1 year was listed as one of the first 55 pilot enterprise groups in the State Council. 1997 was included in the first batch of six technological innovation pilot enterprises of the State Economic and Trade Commission, and it is the only pharmaceutical enterprise at present.
human resources
High-quality staff is the most precious resource of traditional Chinese medicine. Huayao has more than 2,000 engineers and technicians, more than half of whom have senior technical titles, and about one third are R&D personnel. Three people were rated as young and middle-aged experts with outstanding contributions at the national level, six as young and middle-aged experts with outstanding contributions at the provincial level, and 27 as outstanding experts in provincial management. Huayao gives full play to the enthusiasm and creativity of every employee through systematic training, assessment and effective incentives.
development strategy
According to the analysis and prediction of the development environment of Huayao Pharmaceutical Group, combined with its own resource conditions, in order to maintain its advantages in the more intense competitive environment at the beginning of this century and strive for greater development, the overall strategic goal of Huayao Pharmaceutical Group is to remain the first in China and rank among the top 30 pharmaceutical enterprises in the world by 20 10.